Dysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapy
about
Epigenetic modulators as therapeutic targets in prostate cancerA theoretical study on predicted protein targets of apple polyphenols and possible mechanisms of chemoprevention in colorectal cancerChemical probes targeting epigenetic proteins: Applications beyond oncology.Downregulation of histone methyltransferase EHMT2 in CD4(+) T-cells may protect HTLV-1-infected individuals against HAM/TSP development.Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents.Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs.Effects of SMYD2-mediated EML4-ALK methylation on the signaling pathway and growth in non-small-cell lung cancer cells.Critical roles of SMYD2-mediated β-catenin methylation for nuclear translocation and activation of Wnt signaling.Critical roles of protein methyltransferases and demethylases in the regulation of embryonic stem cell fate.Novel prognostic marker PRMT1 regulates cell growth via downregulation of CDKN1A in HCC.Protein methyltransferases and demethylases dictate CD8+ T-cell exclusion in squamous cell carcinoma of the head and neck.Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway.PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signalling.Protein arginine methylation: an emerging regulator of the cell cycle.
P2860
Q28071912-4FF8700D-F002-4925-B273-965F49548B51Q28831453-F552941A-5CA9-4F27-AC56-4DC443FC1368Q33751386-997E1085-C04D-4877-8E86-31B11548A2DFQ38950117-D6203188-775F-4CC3-8EBB-201CB16AB5AAQ39055609-C62D03F1-D570-4108-AD31-51B7616EECA3Q39317584-0A794610-8FA9-4C32-B055-AF772BEF2A83Q41072068-E54916B4-3536-4BC5-B57D-BB917250F6B3Q41348816-C5BBCD64-5BC5-4FD5-B3D1-42FF04FF92D7Q47445776-7FB13207-4F41-44A4-A930-89F06C0A116DQ47547759-7F20DEFC-EA39-4DF2-B814-8F6DCA2A1AE9Q49180652-C5CC5E77-F257-40D4-BE34-CA73B43E3AA7Q49981787-688040A2-1B82-45CD-9EE5-2C387FCC2946Q52617287-05C891EB-4B80-421F-AE2F-E76E88465ECCQ52724818-CEB52EED-F9C3-4998-996A-BFD470ECAE71
P2860
Dysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapy
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Dysregulation of protein methy ...... t class for anticancer therapy
@ast
Dysregulation of protein methy ...... t class for anticancer therapy
@en
Dysregulation of protein methy ...... t class for anticancer therapy
@nl
type
label
Dysregulation of protein methy ...... t class for anticancer therapy
@ast
Dysregulation of protein methy ...... t class for anticancer therapy
@en
Dysregulation of protein methy ...... t class for anticancer therapy
@nl
prefLabel
Dysregulation of protein methy ...... t class for anticancer therapy
@ast
Dysregulation of protein methy ...... t class for anticancer therapy
@en
Dysregulation of protein methy ...... t class for anticancer therapy
@nl
P2860
P3181
P356
P1433
P1476
Dysregulation of protein methy ...... t class for anticancer therapy
@en
P2093
Yusuke Nakamura
P2860
P304
P3181
P356
10.1111/CAS.12884
P407
P5008
P577
2016-04-01T00:00:00Z